Ativo Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Ativo Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-274,065	Closed	-$861K	–	235
2016 Q2	$861K	Buy	+274,065	New	+$914K	0.21%	155
2014 Q3	–	Sell	-26,713	Closed	-$259K	–	208
2014 Q2	$259K	Sell	26,713 -4,470	-14%	-$39.8K	0.11%	153
2014 Q1	$259K	Buy	31,183 +2,806	+10%	+$24.1K	0.11%	171
2013 Q4	$239K	Buy	28,377 +1,906	+7%	+$16.1K	0.1%	171
2013 Q3	$211K	Buy	26,471 +2,829	+12%	+$22.7K	0.1%	174
2013 Q2	$183K	Buy	+23,642	New	+$184K	0.09%	169

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ativo Capital Management's PDLI Position: Q3 2016 in Review

Ativo Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2016, closing a stake of 274,065 shares — an estimated $861K sold.

Ativo Capital Management first reported a position in PDLI in Q2 2013 and held it in 6 quarters. The position peaked at $861K in Q2 2016. 197 funds tracked by Wall St. Rank hold PDLI as of Q3 2016.

Ativo Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2016 after selling out during the quarter.
Ativo Capital Management sold 274,065 PDL BioPharma, Inc. shares in Q3 2016, an estimated $861K.
Ativo Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 6 quarters.
Ativo Capital Management's PDL BioPharma, Inc. position peaked at $861K in Q2 2016.
197 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2016.

Based on Ativo Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.